PRWeb The Leader Press Release Distribution
See How PRWeb Works

We're here to help 1-866-640-6397

Login Create Free Account


All Press Releases for February 21, 2005 Subscribe to this News Feed    
 

Recovery From Sarcoidosis to be Highlighted at Conference March 12-13, 2005

The Autoimmunity Research Foundation is sponsoring a conference March 12-13, 2005, at Chicagos Midway Airport, that will bring together physicians, recovering patients and policy-makers to review an innovative antibacterial therapy that offers hope for effective treatment of several autoimmune diseases including: Sarcoidosis (Reggie Whites disease).

Thousand Oaks, CA (PRWEB) February 21, 2005 -- The Autoimmunity Research Foundation is sponsoring a conference March 12-13, 2005, at Chicagos Midway Airport, that will bring together physicians, recovering patients and policy-makers to review an innovative antibacterial therapy that offers hope for effective treatment of several autoimmune diseases including: Sarcoidosis (Reggie Whites disease), Chronic Fatigue Syndrome, Chronic Lyme Disease, Rheumatoid Arthritis and Fibromyalgia.

The recent death of Reggie White has sparked a national interest in Sarcoidosis. Actors Bernie Mac, Tisha Campbell-Martin and former NBA star Bill Russell have recently announced they are battling this disease.

Sudden death from Sarcoidosis is not as rare as once thought and sometimes the disease is not diagnosed until after death. Chicagos NBC sports anchor, Darrian Chapman, died suddenly of cardiac Sarcoidosis two years ago. Dr. Mark Rosenthal, a nationally recognized Philadelphia cardiologist, died of sudden cardiac arrhythmia due to Sarcoidosis four years ago.

Now it seems that a cure may be on the horizon. This conference will bring together a pioneering group of Sarcoidosis patients and physicians who have shown that it is possible to return to health using a combination of common antibiotics.

The treatment for Sarcoidosis has not changed in fifty years. Patients are allowed to deteriorate without treatment until they are so ill or have enough major organ damage to warrant the use of prednisone, a drug that is not effective at halting the disease, but which can provide short-term relief.

Many doctors believe the widespread myth that Sarcoidosis may go away without treatment. However, the recent national NIH study of Sarcoidosis, ACCESS, conclusively proved that this is not true. This study of Sarcoidosis, the largest ever conducted, revealed that the disease does not resolve on its own, whether treated with prednisone or not. The ACCESS study noted, "Most patients with persistent disease at two years were unlikely to have resolution of Sarcoidosis" and "end stage pulmonary Sarcoidosis usually develops over one or two decades."

The sad tragedy of this disease is that studies dating back to 1972 have been showing that species of bacteria including Mycobacteria, Rickettsia, Borrelia and Propionibacteria are somehow associated with Sarcoidosis. Yet these studies have been largely ignored.

Trevor Marshall, Ph.D., an Autoimmunity Research Foundation director, commented, "Some years ago, we discovered that the bacteria causing these diseases are resistant to antibiotics unless care is taken to reduce two hormones in the bodys endocrine system -- Angiotensin II and 1,25-dihydroxycholecalciferol. That was the breakthrough in understanding these diseases."

This conference brings together this first-ever group of patients to recover from Sarcoidosis, and many of their physicians, with policy makers from the National Institutes of Health (NIH) and the FDA.

A few online registrations are still open for interested patients and physicians at URL: http://autoimmunityresearch.org/chicago2005.htm
Press passes are available.

Conference speakers will include:
- James P. Kiley, Ph.D.- Director of the Division of Lung Diseases, NHLBI, National Institutes of Health
- Lida H. Mattman, Ph.D.- author of the medical textbook Stealth Pathogens
- Leonard Jason, Ph.D.- CFS/CFIDS/ME expert and author (DePaul University)
- Commander Sarah Linde-Feucht, M.D., FDA Office of Orphan Products Development
- Trevor Marshall, Ph.D.- Director, Autoimmunity Research Foundation
- Andy Wright, M.D. -- U.K. researcher investigating bacteriological causes of fatigue disorders

Contact:
Belinda Fenter
Autoimmunity Research Foundation
817-732-7336
Email: belindaf@autoimmunityresearch.org
http://www.autoimmunityresearch.org

# # #

Technorati Tags

Bookmark -  Del.icio.us | Furl It | Technorati | Ask | MyWeb | Propeller | Live Bookmarks | Newsvine | TailRank | Reddit | Slashdot | Digg | Stumbleupon | Google Bookmarks | Sphere | Blink It | Spurl


OPTIONS
Printer Friendly Version
Download PDF Version
Download Reader Version
Email this story to a colleague
CONTACT INFORMATION
Belinda Fenter
Autoimmunity Research Foundation
817-732-7336
Email us Here
ATTACHED FILES

There are no multimedia files attached to this release. If this is your release, you may add images or other multimedia files through your PRWeb News Management Console.

ABOUT PRESS RELEASES
If you have any questions regarding information in these press releases please contact the company listed in the press release. Please do not contact PRWeb. We will be unable to assist you with your inquiry. PRWeb disclaims any content contained in these release. Our complete disclaimer appears here.